These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5735321)

  • 1. Reduction of tissue norepinephrine and blood pressure by 3,5-dihydroxy-4-methoxy-phenylalanine.
    Spector S; Tabei R; Creveling CR; Daly JW; Witkop B; Sjoerdsma A
    Life Sci; 1968 Sep; 7(17):943-9. PubMed ID: 5735321
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of omega-amino-acids on blood pressure, catecholamine stores and the pressor response to physostigmine in the rat.
    Hedwall PR; Maître L; Brunner H
    J Pharm Pharmacol; 1968 Oct; 20(10):737-43. PubMed ID: 4386740
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of tissue norepinephrine depletion by 6-hydroxydopamine on blood pressure in spontaneously hypertensive rats.
    Yamori Y; Yamabe H; De Jong W; Lovenberg W; Sjoerdsma A
    Eur J Pharmacol; 1972 Jan; 17(1):135-40. PubMed ID: 5016572
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of 2-amino-4,5,6,7-tetrahydro-5-propyl-thiazole(5,4-c)pyridine, an antihypertensive and sedative substance, on the noradrenaline storage in the heart of guinea pigs].
    Honjo T; Engelhardt G
    Arzneimittelforschung; 1970 Jun; 20(6):845-50. PubMed ID: 5468901
    [No Abstract]   [Full Text] [Related]  

  • 5. Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1970 Aug; 22(8):553-60. PubMed ID: 4394527
    [No Abstract]   [Full Text] [Related]  

  • 6. Norepinephrine depleting and antihypertensive effect of 4-methoxy-3,5-dihydroxyphenylalanine.
    Thoenen H; Gerold M; Haefely W; Huerlimann A
    Experientia; 1968 Feb; 24(2):158-9. PubMed ID: 4384506
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissociation of the effects of p-chlorophenylalanine on self-stimulation and on brain serotonin.
    Stark P; Fuller RW; Hartlery LW; Schaffer RJ; Turk JA
    Life Sci; 1970 Jan; 9(1):41-8. PubMed ID: 5435853
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypotensive drugs and tissue noradrenaline].
    Jori A; Mortari A; Sioli G; Valzelli L
    Boll Soc Ital Biol Sper; 1964 Nov; 40(22):1421-3. PubMed ID: 5876862
    [No Abstract]   [Full Text] [Related]  

  • 9. Catecholamines concentration in brain and heart tissue of rats and its blood pressure during chronic treatment with a new tricyclic antidepressant 10-(3-dimethylaminopropyl)-7-chlorobenzo-(b), (1,8)-naphthyridone-5 monohydrochloride (IF-C-45).
    Filczewski M; Szymańska-Kosmala M
    Pol J Pharmacol Pharm; 1975; 27(3):277-82. PubMed ID: 1144206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of neonatal 6-hydroxydopamine treatment on the blood pressure response to noradrenaline and tyramine in rats.
    Provoost AP; de Kemp JA; de Jong W
    Eur J Pharmacol; 1973 Sep; 23(3):297-301. PubMed ID: 4746745
    [No Abstract]   [Full Text] [Related]  

  • 11. Norepinephrine and serotonin in the tissues and venoms of 2 pit vipers.
    Anton AH; Gennaro JF
    Nature; 1965 Dec; 208(5016):1174-5. PubMed ID: 5870315
    [No Abstract]   [Full Text] [Related]  

  • 12. Central hypotensive effect of alpha-methyldopa.
    Henning M; Van Zwieten PA
    J Pharm Pharmacol; 1967 Jun; 19(6):403-5. PubMed ID: 4382373
    [No Abstract]   [Full Text] [Related]  

  • 13. Centrally acting alpha-agonists. Mechanisms and their role in the therapy of essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):98-101. PubMed ID: 1071410
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial and splenic levels of catecholamines in burn shock.
    Cova R; Glaviano VV
    Proc Soc Exp Biol Med; 1968 Jul; 128(3):642-5. PubMed ID: 5668100
    [No Abstract]   [Full Text] [Related]  

  • 15. Depletion of cardiac norepinephrine in rats and mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Fuller RW; Hahn RA; Snoddy HD; Wikel JH
    Biochem Pharmacol; 1984 Oct; 33(19):2957-60. PubMed ID: 6333240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological and biochemical effects of hydralazine and dihydralazine].
    van Zwieten PA
    Arzneimittelforschung; 1968 Jan; 18(1):79-84. PubMed ID: 4386976
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of binazin on the levels of biogenic amines in the brain, heart, kidneys, and aorta of the experimental animals.
    Billewicz-Stankiewicz J; Kleinrok HZ; Borzecki Z
    Mater Med Pol; 1974; 6(3):183-7. PubMed ID: 4444333
    [No Abstract]   [Full Text] [Related]  

  • 18. Formation of a "false" adrenergic transmitter in cats pretreated with 4-methyoxy-3,5-dihydroxyphenylalanine and its effects on postganglionic sympathetic transmission.
    Thoenen H; Haefely W; Haeusler G; Huerlimann A
    J Pharmacol Exp Ther; 1968 Jul; 162(1):70-9. PubMed ID: 4297802
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term effects of postnatal 6-hydroxydopamine treatment on tissue catecholamine levels.
    Lytle LD; Shoemaker WJ; Cottman K; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Oct; 183(1):56-64. PubMed ID: 5080034
    [No Abstract]   [Full Text] [Related]  

  • 20. The changes in vitamin B6 and brain amine metabolism in mice chronically treated with delta-9-tetrahydrocannabinol.
    Colombini CE; Westfall TC; McCoy EE
    Act Nerv Super (Praha); 1974 Mar; 16(1):68-9. PubMed ID: 4454949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.